FGEN - FibroGen, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue212,958130,996183,189180,828
Cost of Revenue235,839196,517187,206214,089
Gross Profit-22,881-65,521-4,017-33,261
Operating Expenses
Research Development235,839196,517196,517196,517
Selling General and Administrative63,81251,76046,02544,364
Non Recurring----
Others----
Total Operating Expenses299,651248,277233,231258,453
Operating Income or Loss-86,693-117,281-50,042-77,625
Income from Continuing Operations
Total Other Income/Expenses Net577-373-8,097-7,912
Earnings Before Interest and Taxes-86,693-117,281-50,042-77,625
Interest Expense-10,991-9,706-10,725-11,033
Income Before Tax-86,116-120,554-58,139-85,537
Income Tax Expense304321-71242
Minority Interest19,27119,27119,27119,271
Net Income From Continuing Ops-86,420-120,875-58,068-85,779
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-86,420-120,875-58,068-85,779
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-86,420-120,875-58,068-85,779